CD37產(chǎn)品信息
英文名稱:Leukocyte antigen CD37
中文名稱:白細(xì)胞抗原CD37
靶點(diǎn)別稱:CD37,TSPAN26,Tetraspanin-26
物種:Human
標(biāo)簽:His Tag/Fc Tag
屬性:Protein
標(biāo)記:FITC Labeled/Unconjugated
表達(dá)區(qū)間及表達(dá)系統(tǒng)(Source)
Human CD37, Fc Tag (CD7-H525a) is expressed from human 293 cells (HEK293). It contains AA Arg 112 - Asn 241 (Accession # P11049-1).
Predicted N-terminus: Arg 112
蛋白結(jié)構(gòu)(Molecular Characterization)
This protein carries a human IgG1 Fc tag at the C-terminus.
The protein has a calculated MW of 41.3 kDa. The protein migrates as 50-60 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.
內(nèi)毒素(Endotoxin)
Less than 1.0 EU per μg by the LAL method.
純度(Purity)
>95% as determined by SDS-PAGE.
>90% as determined by SEC-MALS.
制劑(Formulation)
Lyophilized from 0.22 μm filtered solution in 50 mM Tris, 100 mM Glycine, 25 mM Arginine, 150 mM NaCl, pH7.5. Normally trehalose is added as protectant before lyophilization.
Contact us for customized product form or formulation.
重構(gòu)方法(Reconstitution)
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存儲(chǔ)(Storage)
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.
背景(Background)
白細(xì)胞抗原CD37(CD37)也被稱為Tetraspanin-26(Tspan-26)和TSPAN26,TSPAN26是跨膜4超家族或Tetraspanin家族的成員。這些成員中的大多數(shù)是細(xì)胞表面蛋白,其特征是存在四個(gè)疏水結(jié)構(gòu)域。CD37基因編碼的蛋白質(zhì)介導(dǎo)信號(hào)轉(zhuǎn)導(dǎo)事件,這些事件在細(xì)胞發(fā)育、活化、生長(zhǎng)和運(yùn)動(dòng)的調(diào)節(jié)中發(fā)揮作用。CD37是一種已知與整合素和其他跨膜4超家族蛋白復(fù)合的細(xì)胞表面糖蛋白。CD37可能在T細(xì)胞與B細(xì)胞的相互作用中發(fā)揮作用。
關(guān)鍵字: CD37;CD37蛋白;CD37重組蛋白;ACRO;百普賽斯;
百普賽斯集團(tuán)ACROBiosystems Group(股票代碼:301080)是成立于2010年的跨國(guó)生物科技公司,是為全球生物醫(yī)藥、健康產(chǎn)業(yè)領(lǐng)域提供關(guān)鍵生物試劑產(chǎn)品及解決方案的行業(yè)平臺(tái)型基石企業(yè)。2021年在創(chuàng)業(yè)板上市。百普賽斯集團(tuán)業(yè)務(wù)遍布全球,橫跨亞洲、北美洲、歐洲,在中國(guó)、美國(guó)、瑞士等12個(gè)城市設(shè)有辦公室、研發(fā)中心及生產(chǎn)基地。目前累計(jì)服務(wù)客戶超6000家,與全球Top 20醫(yī)藥企業(yè)均建立了長(zhǎng)期、穩(wěn)定的合作伙伴關(guān)系。集團(tuán)旗下?lián)碛衅放艫CROBiosystems百普賽斯、bioSeedin柏思薈、Condense Capital墾拓資本和ACRODiagnostics百斯醫(yī)學(xué)等。